Regulatory Issues Relating to Herbal Products—Part 2: Safety and Toxicity

Cytotoxic effect of Myrtus communis, Aristolochia longa, and Calycotome spinosa on human erythrocyte cells

Introduction. Myrtus communis, Aristolochia longa, and Calycotome spinosa are medicinal plants frequently used in Algeria. Some plants can cause a fragility of the erythrocyte membrane and lead to hemolysis. Therefore, we aimed to study the cytotoxicity of aqueous extracts from the aerial part of these species against red blood cells. Study objects and methods. The hemolytic effect was determined spectrophotometrically by incubating an erythrocyte solution with different concentrations of the aqueous extracts (25, 50, 100, and 200 mg/mL) at 37°C during one hour. In addition, we performed phytochemical screening and measured the contents of polyphenols and flavonoids. Results and discussion. After one hour of incubation of human red blood cells with the aqueous extracts at different concentrations, the hemolysis percentage showed a significant leak of hemoglobin with A. longa (68.75 ± 6.11%; 200 mg/mL), the most toxic extract followed by C. spinosa (34.86 ± 5.06%; 200 mg/mL). In contrast, M. communis showed very low cytotoxicity (20.13 ± 3.11%; 200 mg/mL). Conclusion. These plants are sources of a wide range of bioactive compounds but their use in traditional medicine must be adapted to avoid any toxic effect.

Acute and chronic toxicity of a polyherbal preparation - Jueyin granules

Background

The potential toxicity of Chinese herbal medicine has attracted more attention in recent years. Jueyin granules (JYG), a polyherbal formula, have been proven to be an effective agent for treating psoriasis in both animal models and clinical research. However, little is known about the possible acute and chronic toxicity of JYG. The objective of this study was to investigate the safety of JYG in ICR mice and Wistar rats.

Methods

To examine the acute toxicity of JYG, ICR mice were randomly divided into an experimental group and a control group, each comprising 20 mice (10 male and 10 female). The experimental group was fed JYG solution at a dose of 21.5 g/kg, equivalent to 143 times the clinical human dosage, for 14 days, whereas control animals were fed distilled water. In the chronic toxicity test, Wistar rats were divided into four groups, each comprising 40 rats (20 male and 20 female). For 6 months, the experimental animals were given JYG at a dose of 7.5, 3.75 and 1.875 g/kg, whereas control animals were given distilled water. The animals’ body weight, food and water consumptions were monitored weekly. In addition, their biochemical and hematological parameters, histopathology, and body and organ weights were all measured at specific observation time points.

Results

According to the results of the acute toxicity test, no mortality was found and no abnormal pathological changes in major organs were observed in mice treated with JYG. In the chronic toxicity test, JYG did not cause significant abnormalities in the physiological parameters or pathological changes in the major organs of the rats.

Conclusion

The results indicated that JYG at the given doses did not induce any harmful effects in animals. Thus, it is reasonable to conclude that JYG is safe at the studied dosage levels and causes no acute or chronic toxicity in animal models.

Electronic supplementary material

The online version of this article (10.1186/s12906-018-2211-z) contains supplementary material, which is available to authorized users.

Regulatory issues relating to herbal products-part 3: quality and its determination

ABSTRACT The concept of quality in the manufacture of herbal products is directed toward ensuring that the required standard of product is attained through processes that involve good manufacturing practice and quality control. This article reviews the need for quality assurance of herbal products, approaches taken by regulatory authorities in Europe to address this issue, and analytical methods applicable to the evaluation of herbal products. The natural ingredients that are used to prepare herbal products give rise to problems that are not encountered with conventional medicinal products. Quality standards are applied to both starting materials and finished products. Pharmacopoeial monographs, even when not forming part of official compendia, lay down criteria for analytical testing, including materials and methods, test limits, and acceptance ranges for results. Analytical tests are employed to establish the identity of the plant material or of the active principles, the content of active principles or characteristic marker compounds by assay, and the purity of the product by exclusion of specific adulterants or contaminants. Advances in instrumentation and test methods provide the analyst with powerful tools to determine the level of quality. Nevertheless, there still exist limitations to testing because of the complex and variable nature of the herbal ingredients. The standards and requirements for quality of herbal products as applied in the European Union are also intended to provide further assurances on the efficacy and safety of products.